ARPA-H, diversity in clinical trials bills advance through committee

ARPA-H to award up to $150M to develop novel technologies for precise tumor removal 

The Advanced Research Projects Agency for Health announced the first eight teams selected by its Precision Surgical Interventions, or PSI, program to receive awards.

September 06, 2024

Vol.50 No.33

In Brief

UIUC receives $18.7M from ARPA-H to develop platform for rapid manufacturing of tumor models

Bill King, a researcher with the University of Illinois Urbana-Champaign, received a $18.7 million award from the Advanced Research Projects Agency for Health to develop a novel platform to manufacture tumor models and dramatically expand their availability for both medical research and personalized medicine.

September 06, 2024

Vol.50 No.33

Capitol Hill

Senate Appropriations Committee slates $1.77B increase for NIH, $270M for NCI in FY25

The Senate Appropriations Committee voted to provide significant increases to federal health agencies in fiscal year 2025, including raises of nearly $2 billion for NIH and $270 million for NCI.

August 09, 2024

Vol.50 No.32

By Matthew Bin Han Ong

In Brief

Alex Morozov named chief medical officer at Pi Health

Alex Morozov was named the first chief medical officer of Pi Health, an oncology clinical trial and research technology company.

August 09, 2024

Vol.50 No.32

Clinical Trials & Tribulations

Of adaptive and factorial designs
A biostatistician’s interpretation of last week’s ODAC

At its most recent meeting, the FDA Oncologic Drugs Advisory Committee focused on perioperative clinical trials, which the agency defined as neoadjuvant phase followed by surgery and continuing with adjuvant treatment using the same experimental agent (The Cancer Letter, July 26, 2024).

Language barriers hinder diverse recruitment to clinical trials

Underrepresentation of racial and ethnic minority populations in cancer clinical trials persists partly because translation and interpretation services and resources are unavailable or inadequate in the United States, according to a Children’s Oncology Group study led by Columbia University School of Nursing.

August 02, 2024

Vol.50 No.31

ARPA-H, diversity in clinical trials bills advance through committee

YOU MAY BE INTERESTED IN

ARPA-H to award up to $150M to develop novel technologies for precise tumor removal

UIUC receives $18.7M from ARPA-H to develop platform for rapid manufacturing of tumor models

Senate Appropriations Committee slates $1.77B increase for NIH, $270M for NCI in FY25

Alex Morozov named chief medical officer at Pi Health

Of adaptive and factorial designs
A biostatistician’s interpretation of last week’s ODAC

Language barriers hinder diverse recruitment to clinical trials

Renew today!

Subscriber content

Can you spare 10 minutes to complete a survey?

Login

ARPA-H, diversity in clinical trials bills advance through committee

YOU MAY BE INTERESTED IN

ARPA-H to award up to $150M to develop novel technologies for precise tumor removal

UIUC receives $18.7M from ARPA-H to develop platform for rapid manufacturing of tumor models

Senate Appropriations Committee slates $1.77B increase for NIH, $270M for NCI in FY25

Alex Morozov named chief medical officer at Pi Health

Of adaptive and factorial designsA biostatistician’s interpretation of last week’s ODAC

Language barriers hinder diverse recruitment to clinical trials

Can you spare 10 minutes to complete a survey?

Login

ARPA-H to award up to $150M to develop novel technologies for precise tumor removal 

Of adaptive and factorial designs
A biostatistician’s interpretation of last week’s ODAC